Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized 3% hypertonic saline for acute bronchiolitis
NCT02029040Completed
- Sponsor
- UT Southwestern Medical Center
- Start
- Dec 2013
- Primary completion
- Dec 2014
- Modality
- Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
Randomised, double-blind trial of hypertonic saline in acute bronchiolitis, sponsored by UT Southwestern Medical Center. Primary endpoint: Respiratory Assessment Change Score. Started Dec 2013; status: completed.
02
Drugs
hypertonic saline
03
Conditions
acute bronchiolitis
Beyond the preview
Go deeper on NCT02029040.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02029040.